Back

Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction

29 April 2022 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster Session 1 Heart Failure CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Marialucia Telesca

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

73 More presentations in this session

Presentation thumbnail
Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients
Miss E. Bevilacqua (Seville, ES)
Abstract
Presentation thumbnail
Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring
Doctor K. Viligorska (Chernivtsi, UA)
Abstract
Presentation thumbnail
Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study
Mr C. Rios Navarro (Valencia, ES)
Abstract
Presentation thumbnail
Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion
Associate Professor L. Tacu (Chisinau, MD)
Presentation thumbnail
Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets
Doctor B. Agg (Budapest, HU)
Abstract

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

29 April 2022 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Fetal recapitulation and cellular stress in the evolution and progression of heart failure
thumbnail
Congress Session
Heart Failure 2025 highlights
thumbnail
Congress Session
Unspoken aetiologies of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources